Pre-exposure prophylaxis (PrEP) is a vital part of ending HIV, but ads targeting people to join lawsuits are planting needless fears in patients, three leading HIV specialists write.
What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription
Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.
We're covering the latest news and research from this major interdisciplinary meeting on infectious diseases, which takes place in Washington, D.C., from Oct. 2 to Oct. 6.
This inspiring moment from the U.S. Conference on AIDS illustrates how relationships can produce results for advocates.
The ECHO trial faces backlash and criticism.
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
"A lot of patients want to know, 'Who else is going to see this data?'" said Peter Chai of Fenway Health in Boston.
New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.
Best practices need to be replicated, but our health care structure will make doing so more challenging, says Ace Robinson of the Fast-Track Cities initiative.
TheBodyPro is covering all the latest in HIV science at the biggest annual gathering of HIV researchers in the U.S. Here's a preview of what's to come.